Simpler Grants.gov #PAR-25-032

NHLBI Grant for Clinical Trial Pilot Study Research Services

The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is seeking applications for pilot studies to support the planning of future clinical trials in heart, lung, blood, and sleep disorders. - Government Buyer: - National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI) - No Original Equipment Manufacturers (OEMs) or specific vendors are named, as this is a grant for research services, not a product procurement. - Products/Services Requested: - Research services for pilot studies to inform the design and planning of Phase II-IV clinical trials - Focus areas include efficacy, safety, clinical management, or implementation of interventions for heart, lung, blood, and sleep disorders - Unique or Notable Requirements: - Open to a broad range of applicants, including educational institutions, government entities, nonprofits, businesses, tribal organizations, and non-U.S. entities - No specific products, part numbers, or purchase quantities are specified - The grant is intended to generate results that will inform future clinical trials within NHLBI's mission areas

Description

This Notice of Funding Opportunity Announcement (NOFO) supports studies necessary and sufficient to inform the planning of a Phase II-IV clinical trial within NHLBI's mission. Applications should describe the planned clinical trial and demonstrate that the proposed (R34) research is scientifically necessary for designing or planning the subsequent trial. The research should provide results sufficient to inform the future trial without further studies. The trial must primarily test the efficacy, safety, clinical management, or implementation of interventions for heart, lung, blood, and sleep disorders. The R34 mechanism aims to answer scientific or operational questions that inform the final development of a Phase II-IV clinical trial.

View original listing